Trends in progression-free survival (PFS) and time to progression (TTP) over time within first-line aromatase inhibitors trials in hormone receptor-positive advanced breast cancer
Crossref DOI link: https://doi.org/10.1007/s10549-017-4593-x
Published Online: 2017-11-30
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Reinert, T. http://orcid.org/0000-0003-4715-1415
Debiasi, M.
Bines, J.
Barrios, C. H.
License valid from 2017-11-30
